Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Inzone Preload is a macro-nutrient dietary supplement composed entirely of natural food ingredients, including pea protein, whey protein, egg albumin, omega-3 and omega-6 fatty acids, whole eggs, apple, rosehip, and sugar. It is designed as a preload intervention to be consumed before meals to modulate postprandial glucose excursions in individuals with type 2 diabetes mellitus (T2DM). The formulation provides high protein content with low carbohydrates and includes polyunsaturated fatty acids, dietary fiber, and vitamin C. Clinical studies have shown that regular use of Inzone Preload can reduce postprandial blood glucose levels (2 h-BG), HbA1c values, total cholesterol, LDL cholesterol, C-reactive protein (CRP), and may support weight loss in some patients with T2DM. No significant adverse effects were reported during clinical evaluation[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Inzone Preload.